The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets

The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets Aims: The prescription of optimal medical therapy for heart failure is often delayed despite compelling evidence of a reduction in mortality. We calculated the absolute risk resulting from delayed prescription of therapy. For [...]

2023-02-22T14:19:28-04:00November 1st, 2017|

Remote management of heart failure using implantable electronic devices

Remote management of heart failure using implantable electronic devices Aims: Remote management of heart failure using implantable electronic devices (REM-HF) aimed to assess the clinical and cost-effectiveness of remote monitoring (RM) of heart failure in patients with cardiac implanted electronic devices (CIEDs). Methods and results: Between 29 September 2011 and 31 March 2014, we randomly assigned 1650 [...]

2023-02-22T14:12:01-04:00August 7th, 2017|

Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews

Remote Monitoring of Patients With Heart Failure: An Overview of Systematic Reviews Background Many systematic reviews exist on the use of remote patient monitoring (RPM) interventions to improve clinical outcomes and psychological well-being of patients with heart failure. However, research is broadly distributed from simple telephone-based to complex technology-based interventions. The scope and focus of [...]

2023-03-02T19:00:40-04:00January 20th, 2017|

Telemonitoring Reduced Costs and Inpatient Visitation Rates for Patients with Advanced Cardiovascular Disease: A Matched Cohort Study Telemonitoring Reduced Costs and in-Patient Visitation Rates for Patients with Advanced Cardiovascularddisease

Telemonitoring Reduced Costs and Inpatient Visitation Rates for Patients with Advanced Cardiovascular Disease: A Matched Cohort Study Telemonitoring Reduced Costs and in-Patient Visitation Rates for Patients with Advanced Cardiovascularddisease Introduction: Reducing the cost of care of patients with cardiovascular disease is an important target for integrated health systems. Managing these patients is difficult and costly, with [...]

2023-03-02T18:53:11-04:00August 2nd, 2016|

Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials

Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials Aims: To assess the overall effect of telemedicine on diabetes management and to identify features of telemedicine interventions that are associated with better diabetes management outcomes. Methods: Hedges's g was estimated as the summary measure of mean difference in HbA1c between [...]

2023-02-22T14:05:20-04:00June 1st, 2016|

Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition — Heart Failure (BEAT-HF) Randomized Clinical Trial

Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial Importance: It remains unclear whether telemonitoring approaches provide benefits for patients with heart failure (HF) after hospitalization. Objective: To evaluate the effectiveness of a care transition intervention using remote patient monitoring in [...]

2023-02-22T14:20:02-04:00March 1st, 2016|

Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial

Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial Background: In the CHAMPION trial, significant reductions in admissions to hospital for heart failure were seen after 6 months of pulmonary artery pressure guided management compared with usual care. We examine the extended efficacy [...]

2023-02-22T15:27:09-04:00January 22nd, 2016|

Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent’s Screening TO Prevent Heart Failure) study

Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study Aims: Prevention of cardiovascular disease and heart failure (HF) in a cost-effective manner is a public health goal. This work aims to assess the cost-effectiveness of the St Vincent's Screening TO Prevent Heart Failure (STOP-HF) [...]

2023-02-22T14:18:51-04:00July 1st, 2015|

Can telemonitoring reduce hospitalization and cost of care? A health plan’s experience in managing patients with heart failure

Can telemonitoring reduce hospitalization and cost of care? A health plan's experience in managing patients with heart failure Telemonitoring provides a potentially useful tool for disease and case management of those patients who are likely to benefit from frequent and regular monitoring by health care providers. Since 2008, Geisinger Health Plan (GHP) has implemented a [...]

2023-02-22T15:30:06-04:00December 1st, 2014|

Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis

Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis Emerging telemedicine programs offer potential low-cost solutions to the management of chronic disease. We sought to evaluate the clinical effectiveness and cost effectiveness of telemedicine approaches on glycemic control in patients with type 2 diabetes mellitus. Using terms related to [...]

2023-02-22T14:04:43-04:00December 1st, 2014|
Go to Top